Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 896,692 |
|
|||||
| News | (3) | ||||||
| Day High | 12.42 | Low High |
|||||
| Day Low | 11.87 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Y mAbs Therapeutics Inc | YMAB | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.09 | 0.75% | 12.10 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 12.01 | 11.87 | 12.42 | 12.10 | 12.01 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,762 | 896,692 | US$ 12.07 | US$ 10,820,518 | - | 4.60 - 20.90 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:20:00 | priorref | 4,301 | US$ 12.10 | USD |
Y mAbs Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 527.95M | 43.78M | - | 84.82M | -21.43M | -0.49 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Y mAbs Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical YMAB Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.36 | 12.76 | 11.79 | 12.16 | 293,830 | -0.26 | -2.10% |
| 1 Month | 17.50 | 17.7775 | 11.15 | 13.04 | 422,265 | -5.40 | -30.86% |
| 3 Months | 17.64 | 18.105 | 11.15 | 14.44 | 359,944 | -5.54 | -31.41% |
| 6 Months | 6.42 | 20.90 | 6.00 | 13.02 | 368,519 | 5.68 | 88.47% |
| 1 Year | 8.36 | 20.90 | 4.60 | 10.55 | 285,901 | 3.74 | 44.74% |
| 3 Years | 35.96 | 39.8199 | 2.70 | 10.92 | 405,220 | -23.86 | -66.35% |
| 5 Years | 20.90 | 55.36 | 2.70 | 17.34 | 329,930 | -8.80 | -42.11% |
Y mAbs Therapeutics Description
| Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others. |
